AMRI Proposes To Close UK-Based API Manufacturing Facility
News Feb 20, 2015
AMRI has announced its intention, subject to consultation with its UK workforce, to close its UK facility in Holywell, Wales, which provides chemical development services and small- and large-scale manufacturing services of active pharmaceutical ingredients (API).
"The original strategy for the Holywell site has been to act as a conduit between Europe and the United States. However, the site has not been able to do this in a way that maximises value for our customers and shareholders and is not aligned to the new strategic direction of the company," said William S. Marth, president and chief executive officer, AMRI. "We continue to move forward with our strategy to be the preeminent supplier of custom and complex end-to-end services to the pharmaceutical industry, which includes the development and manufacture of high-value, niche active pharmaceutical ingredients (APIs)."
The proposed closure of the U.K.-based operation may affect approximately 64 positions. The company is commencing consultation with employee representatives to consider ways of avoiding the proposed redundancies, reducing the number of redundancies and mitigating the impact of the redundancies. The company has no further information to provide at this stage, pending the outcome of consultation with its employees.
Domainex Appoints Dr Bodo Spori as Head of Business Development for EuropeNews
Domainex Ltd, a privately-owned drug discovery services company, is pleased to announce the appointment of Dr Bodo Spori as Head of Business Development for Europe.READ MORE
Empowering Women in Technology Key to Boosting UK EconomyNews
A new report launched at London Stock Exchange for International Women’s Day, reveals the critical role women play in driving economic growth across the UK, with detailed research on 1,279 women-led companies showing a total contribution of £25.9 billion in revenue to the UK economy.READ MORE
Synthetic Biology Breakthrough Means Bacteria Could Produce Our Essential DrugsNews
Bacteria could be programmed to efficiently produce drugs, thanks to breakthrough research into synthetic biology using engineering principles.READ MORE
Comments | 0 ADD COMMENT
Highly Potent Active Pharmaceutical Ingredients (HPAPI)
May 21 - May 22, 2018